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Animal Model of Isolated Gonadotropin Deficiency
I. Hormonal Responses to LHRH Immunoneutralization
BRUCE D. SCHANBACHER, HUGH F. ENGLISH, DOUGLAS GROSS,
RICHARD J. SANTEN, MICHAEL F. WALKER, AND RICHARD E. FALVO
Five intact male mongrel dogs, characterized by an ep-
isodic secretory pattern of LH and normal serum tes-
tosterone concentrations, were actively immunized
against LHRH by subcutaneous injections of 200 g of
a LHRH-human serum albumin conjugate at 0, 4, and
8 weeks. After 12 weeks, two dogs having the highest
antibody titers to LHRH (25% and 51% binding of
I-LHRH in serum diluted 1:1000 B/Bo) had low to non-
detectable serum concentrations of LH and testos-
terone, whereas serum FSH concentrations were sig-
nificantly reduced in only one of these dogs. Immu-
nocytochemical techniques showed that the pituitaries
of these same two dogs had smaller and fewer LH im-
munoreactive gonadotropes than did the pituitaries of
another three immunized-nonaffected dogs or of the
five nonimmunized control dogs. The two LHRH-im-
munized dogs characterized by hypogonadotropism also
had reduced testis (4.0 and 4.0 g) and prostate (2.1 and
1.7 g) weights when compared to control dogs (testis:
12.1 ± 1.0 g and prostate: 9.2 ± 1.9 g). LHRH antibody
titers in three immunized dogs were demonstrable (8.1,
9.8, and 14.2% B/Bo), but effects on LH, FSH, and tes-
tosterone concentrations, pituitary gonadotropes, and
reproductive tissue weights were not apparent. The
similarity in hormonal and tissue responses observed
between dogs effectively immunized against LHRH and
men with isolated gonadotropin deficiency suggests that
the LHRH-immunized dog may provide a suitable ex-
perimental model for the study of patients with isolated
gonadotropin deficiency.
Key words: hypogonadotropic-hypogonadism, lutein-
izing hormone releasing hormone; pituitary, serum LH,
serum FSH, serum testosterone, dog, immunohypo-
physectomy.
Isolated gonadotropin deficiency occurs as an
autosomal dominant syndrome in man and pro-
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duces sexual infantilism as a result of androgen
deficiency (Santen and Paulsen, 1973a,b; Santen
and Kuhn, 1981). Patients with this disorder have
been used to study the effects of gonadotropin re-
placement therapy on Leydig cell and spermato-
genic function (Paulsen et al, 1970; Sherins et al,
1977). However, the constraints of clinical research
limit the scope of such studies. An animal model
of this syndrome would allow more intensive in-
vestigation with gonadotropin replacement therapy
under a variety of experimental conditions. In our
studies, LHRH immunoneutralization was chosen
because of the specificity of this approach and its
proven effectiveness in inducing gonadotropin de-
ficiency in other species. Active immunization
against LHRH results in testicular involution and
decreased serum testosterone concentrations in the
rat (Fraser et al, 1974b), rabbit (Arimura et al, 1973),
ram (Schanbacher, 1982), bull (Robertson et al,
1979), and monkey (Chappel et al, 1980).
The dog was chosen as a model for induced go-
nadotropin deficiency since both hypothalamic-
pituitary-gonadal interrelationships Oones and
Boyns, 1974; DePalatis et al, 1978; Falvo et al, 1979)
and spermatogenesis (Foote et al, 1972) have been
thoroughly studied in this species. Furthermore,
the size of these animals, their availability, and
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their docility allow for frequent blood sampling and
pulsatile administration of gonadotropins under
experimental conditions. The study herein reports
on pituitary and testicular hormone secretion in
adult male mongrel dogs following active immu-
nization against LHRH. Changes in testis and
prostate weights were used as additional indices
of the effectiveness of LHRH immunization.
Animals
Materials and Methods
Ten sexually mature male mongrel dogs weighing 16
to 22 kg, and having normal palpable testes, were used
in the present study. The dogs were housed in indi-
vidual cages in a controlled environment (14L:1OD pho-
toperiod and 18-20 C) at the Milton S. Hershey Animal
Care Facility and were assigned to one of two groups:
LHRH-immunized dogs (A-E) and control dogs (F-J).
Water and Purina Dog Chow were provided ad libitum
during a 2-week acclimation period and throughout the
12-week experimental period.
Immunization Against LHRH
LHRH that had been conjugated to human serum al-
bumin (hSA) by the carbodiimide reaction (Fraser et al,
1974a) was emulsified by sonication in equal volumes of
sterile saline and Freund’s complete adjuvant (Difco
Laboratories, Detroit, Michigan). Dogs A-E were each
administered subcutaneously 200 p.g of the LHRI-I-hSA
conjugate as described previously for ram lambs (Schan-
bacher, 1982). Booster injections of 200 p.g LHRH-hSA
in Freund’s incomplete adjuvant were given to each dog
at four and eight weeks after the initial immunization.
Antibody Titers to LHRH
Antibody titers to LHRH were determined in serum
pools from each dog, before (week 0) and after (week 4,
6, 8, 10, and 12) LHRH immunization, by the following
procedure. Serum pools from each of the immunized
dogs were diluted 1:100 and 1:1000 with phosphate buff-
ered saline containing 0.2% gelatin, whereas sera col-
lected from control dogs at the end of the study were
diluted 1:100 only. The diluted sera (400 itl in duplicate)
were placed in 12 x 75 mm culture tubes with 20,000
cpm of 1251-LHRH (100 d; 1500 CiJmol) and incubated
over night at 4 C. The radioiodinated LHRH used for
binding was prepared by reacting 2.5 p.g LHRH with 0.5
mCi of 1251 (New England Nuclear, Boston, Massachu-
setts) and 4 i.g of chloramine T. Mono-iodinated LHRH
was separated from the other reaction products by QAE
Sephadex chromatography (Nett and Adams, 1977). Free
and bound 1I-LHRH were separated by the addition of
100 p.1 of dextran-treated charcoal. Following centrifu-
gation, the supernatants were transferred to 12 x 75
mm culture tubes and counted in a Packard gamma
spectrometer (3365). Nonspecific binding, determined for
the pre-immunization serum pool from each dog, was
subtracted to estimate the percentage of 1251-LHRH spe-
cifically bound (% B/Bo) in serum of LHRH-immunized
dogs.
Pituitary and Testicular Responses
Peripheral blood samples were collected from dogs A-
#{163}at 20-minute intervals for six hours via indwelling ex-
ternal jugular catheters immediately before LHRH im-
munization, and again at the end of the study (week
12). Additional samples (n = 3) were collected via jug-
ular catheters at 20-minute intervals during weeks 4, 6,
8, and 10 of the study. Serum concentrations of LH
(DePalatis et al, 1978), FSH (Winter et al, 1982) and tes-
tosterone (Schanbacher and D’Occhio, 1982) were de-
termined in duplicate within single assays by previously
described double antibody radioimmunoassay proce-
dures. Sensitivities for the respective assays were 0.5 ng
LER-1685-1/ml for LH, 62.5 ng LER-1685-3A/ml for FSH,
and 0.1 ng/ml for testosterone.
Twelve weeks after immunization, the five immu-
nized dogs (A-E) and five control dogs (F-J) were
weighed and sacrificed by euthanasia. The pituitary,
testes and prostate of each animal were collected,
weighed, and retained for histological examination.
Pituitary Immunocytochemistry
The pituitary glands of dogs A-E and C-I were fixed
by immersion in 2% paraformaldehyde and 2.5% glu-
taraldehyde, post-fixed in 1% osmium tetroxide, and
embedded in Epon 812. Sections were processed for light
microscopic immunocytochemistry according to the per-
oxidase-antiperoxidase procedure (Stemberger et al, 1970)
as modified for use on plastic-embedded, osmium-fixed
tissues (Erlandsen et al, 1979). Gonadotropes were iden-
tified using an antiserum generated against ovine LH.
Immunoabsorption controls using a variety of purified
hormones (Baker and Gross, 1978) demonstrated the high
degree of specificity of this antiserum. At least nine sec-
tions taken from varying levels of the pars distalis were
examined for each dog. The number of immunoreactive
gonadotropes per section showing a distinct nuclear
profile was counted and expressed as a function of the
area of tissue in the section. Additionally, the cross-sec-
tional area of these cells was determined as follows: two
random fields per section were photographed and
printed at a final magnification of 1680 x. Area of indi-
vidual cells was determined with a Zeiss Videoplan dig-
itizing system, which provides automated, computer-
interfaced analysis of the area of cells outlined with an
electronic cursor. Differences between immunized and
control groups were determined by Student’s t test.
Results
Antibody Response to LHRH Immunization
The LHRH antibody titers were less than 3% in
sera of all dogs before LHRH immunization. This
was considered to represent nonspecffic binding,
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TABLE 1. LHRH Antibody Titers, Paired Testes Weights and Prostate Weights in
Control and LHRH-immunized Mongrel Dogs
Testes Prostate
Treatment
Animal
Weight
(kg)
Antibody
Titers
(% B/Bo)*
Weight Weight
(gm) (gm/kgBW) (gm) (gm/kgBW)
Immunized Dogs
Affected
C 19.5 51.2 4.0 0.21 2.1 0.11
D 16.6 28.5 4.0 0.24 1.7 0.10
Unaffected
A 19.7 14.2 14.4 0.75 13.4 0.70
B 22.7 8.1 18.4 0.81 15.1 0.67
E 19.9 9.8 16.8 0.84 15.3 0.77
Control Dogs
F 15.5 ND 15.4 0.99 11.3 0.73
G 17.3 ND 10.6 0.61 15.8 0.91
H 16.0 ND 10.0 0.63 7.2 0.45
I 16.8 ND 11.7 0.70 5.1 0.30
J 16.0 ND 12.7 0.79 6.6 0.41
16.3 - 12.1 0.74 9.2 0.56
± SEM ± 0.3 ± 1.0 ± 0.07 ± 1.9 ± 0.11
* Percentage of [1251]-LHRH binding in serum diluted 1 :10.
ND = nondetectable (<3% at 1:102 dilution).
and was therefore subtracted from the LHRH
binding by sera of immunized dogs.
Titers of LHRH antibodies increased at different
rates in each of the immunized dogs, with the
highest titers observed in dog C, and the lowest
titers observed in dog B (Table 1). Except for dog
C, the immunized dogs had higher binding titers
during weeks 6 and 10 (ie, 2 weeks after the booster
injections) than during weeks 8 and 12 (ie, 4 weeks
after the booster injections).
Endocrine Responses to LHRH Immunization
Mean serum concentrations of LH, FSH, and
testosterone are presented for the five immunized
dogs in Table 2. Before immunization, LH and tes-
tosterone concentrations fluctuated markedly
during the six-hour bleed (Fig. 1, left panel),
whereas FSH concentrations were relatively static
(data not shown). Conspicuous LH peaks were ob-
served in each of the dogs, and in most cases, these
were followed by transient rises in serum testos-
terone. The greater number and amplitude of LH
peaks observed in dogs B and C resulted in higher
mean LH concentrations for these dogs, but mean
serum testosterone concentrations were not ele-
vated.
With the exception of an increase in mean serum
testosterone in dog B during the last bleed (Table
TABLE 2. Serum Hormone Concentrations in Intact Mongrel
Dogs Before and After Active Immunization Against
Luteinizing Hormone Releasing Hormone (LHRH)
Dog
UI
(ng/mI)
Before After
F
(ng
Before
SF1
/mI)
After
Testosterone
(ng/ml)
Before After
A 4.4 2.7 112 120 2.9 2.6
B 9.1 11.4 119 94 1.8 7.8*
C 11.7 ND* 148 92* 1.4 0.3’
D 4.4 ND* 107 90 1.9 0.1*
E 5.9 5.1 120 124 2.8 2.4
Values are mean concentrations for a 6-hour intensive bleed
the day before and 12 weeks after LHRH immunization.
ND = nondetectable (<0.5 ng/ml).
* P < 0.01. Significantly different from pre-immunization con-
centration (paired t test).
C_ [4
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-
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Fig. 1. Serum LH (#{149})and testosterone (-, shaded area)
profiles in five mongrel dogs (A-E) one day before (left panel),
and 12 weeks after (right panel) LHRH immunization.
2 and Fig. 1), marked changes were not observed
in the endocrine parameters of dogs A, B, and E
during the course of this study. Dogs C and D, on
the other hand, had low serum LH concentrations
(<0.8 ng/ml) at 10 and 12 weeks, and low serum
testosterone concentrations (<0.6 ng/ml) as early
as week 8. Figure 1 contrasts the secretory profiles
of dogs C and D before and after immunocastra-
tion was imposed. Serum FSH was significantly
reduced in dog C at the end of the study; however,
the reduction was small in comparison to that ob-
served for serum LH.
Pituitary Gonadotropes
No changes were noted in the size, number, dis-
tribution, or staining intensity of the immunoreac-
tive gonadotropes of dogs A, B, and E as compared
to the control dogs. However, gonadotropes from
dogs C and D were considerably smaller, fewer in
number, and less intensely stained than control
cells (Fig. 2, Table 3).
Testes and Prostate Responses to LHRH Immunization
Weights of both LHRH-immunized and control
dogs at the time of sacrifice are presented in Table
1, along with testis and prostate weights. Because
of weight differences between individual dogs,
testis and prostate weights are also expressed as a
function of body weight. Whether expressed in ab-
solute weight or as a function of body weight, the
testes and prostates of dogs C and D were con-
spicuously small, ie, approximately one-fourth (for
testes) and one-seventh (for prostate) the weights
of control tissues. The heavier weights of the testis
and prostates from immunized dogs, A, B, and E,
and control dogs, F-J, suggest that antibody titers
in the immunized group were either inadequate or
not of sufficient affinity to induce testicular invo-
lution.
Discussion
The present study describes the pituitary and
testicular endocrine responses of intact male mon-
grel dogs to active immunization against LHRI-I.
The results demonstrate that antibodies to LHRH
can be generated in this species by injection of mi-
crogram quantities of LHRH conjugated to human
serum albumin. When produced in sufficient
amounts, the LHRH antibodies can effectively
lower LH levels, presumably through immuno-
neutralization of endogenous LHRH. In turn, the
pituitary gonadotropes regress, serum concentra-
tions of LH and testosterone are decreased, testis
size is diminished, and weight of the prostate gland
is reduced.
The hormonal and tissue responses observed in
dogs C and D closely resembled the findings in
patients with incomplete isolated gonadotropin
deficiency. These subjects have undetectable levels
of LH, low testosterone levels, and reduced testis
size (Santen and Paulsen, 1973a,b; Santen and
Kulin, 1981). On the other hand, FSH is affected
to a lesser extent in isolated gonadotropin defi-
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ciency, as in the two dogs effectively immunized
against LHRH (Santen et al, 1971; Santen and
Paulsen, 1973b; Williams et al, 1975). Since isolated
gonadotropin deficiency in man appears to be sec-
ondary to LHRH deficiency, it was anticipated that
LHRH immunoneutralization in dogs would pro-
Fig. 2. Semi-thin Epon sections of pituitary pars distalis, im-
munostained for gonadotropes with anti-ovine LH 573, rd 1:1000,
in dogs immunized against LHRH. (Magnification x300. A) Dog
H. Gonadotropes are large, well-stained, and distributed throughout
the gland. B) Dog A. Gonadotropes are similar in size and number
to control dog H. C) Dog C. Note the marked reduction in size,
number, and staining intensity of labeled cells.
duce similar effects. Although the responses in in-
dividually immunized dogs were variable, the af-
fected dogs would appear to serve as useful ex-
perimental models to evaluate the responses to
pulsatile and constant modes of gonadotropin re-
placement therapy.
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TABLE 3. Size and Distribution of Gonadotropes in the
Pituitaries of Control and LHRH-immunized Mongrel Dogs
Size of LH Number of LH
Immunoreactive Immunoreactive
Gonadotropes Gonadotropes
Treatment (p.2) (#/2 x 10)
Immunized Dogs
Affected
C 101±26 35±7
D 100±24 48±6
Unaffected
ABE 185±18 79±13
Control Dogs
G-I 203±22 78±11
Values are means ± SE.
Findings similar to those described above have
been reported for LI-IRH-immunized males of other
species. Fraser et al (1974b) reported that active
immunization to LHRH results in atrophy of the
testes and secondary reproductive organs and con-
comitant aspermatogenesis in male rats. De-
creased serum LH and gonadal atrophy have also
been reported in a proportion of rabbits (Arimura
et al, 1973) and male rhesus monkeys (Chappel et
al, 1980) immunized against LHRH. Immunization
of ram lambs against the same antigen as was used
in the present study with dogs (LHRH-hSA), re-
sulted in a “castration response” in all lambs
(Schanbacher, 1982), suggesting that lambs are
more susceptible to the immunocastration proce-
dure. Although it is possible that lambs are more
susceptible to the immunoneuralizing effects of
LHRH antibodies, or that species differences exist
for the neuroendocrine requirements of pituitary
gonadotropin secretion, the more plansible expla-
nation is that dogs simply did not respond ade-
quately to the immunological challenge. Alterna-
tively, differences between the two studies may be
related to differences in the neuroendocrine inputs
necessary for normal testicular function between
pre- and postpubertal animals.
The production of high titer LHRH antisera and
the induction of a “hypophysectomy-like re-
sponse” in immunized dogs C and D provide in-
centive for further development of this immuno-
logical approach to producing gonadotropin defi-
ciency. Even though antibody titers were measured
in dogs A, B, and E following LHRH immuniza-
tion, serum hormone concentrations and testes
weights were normal. An inverse relationship be-
tween LHRH antibody titers and serum concentra-
tions of reproductive hormones has been reported
in immunized male rats (Fraser et al, 1974b), rhesus
macaques (Chappel et al, 1980), and bulls (Rob-
ertson et al, 1981). Based on previous findings
(Fraser (1982), and those reported in the present
study, it is suggested that LHRH antibody titers in
excess of 25% BfBo at 1:1000 dilution are required
to provide effective immunoneutralization of LHRH
in the dog. To improve on the success rate of im-
munohypophysectomy, and at the same time con-
serve on the amounts of purified immunogen re-
quired for successful immunization, an appro-
priate combination of potent immunogen with
potent and safe immunologic adjuvants is re-
quired. While the potent and commonly used
Freund’s complete adjuvant has been utilized in
all of the LHRH immunization experiments to date,
the question of adjuvant safety necessitates the
testing and implementation of new and acceptable
adjuvants.
LHRH immunoneutralization could also be em-
ployed as an effective sterilant for the control of
populations of dogs and other pets. However,
modifications of the present technique are re-
quired before testing commercially. The minimal
number of booster injections required for steriliza-
tion should be known, as well as the reversibility
of this procedure. The observed decrease in the
antibody titers between 2 and 4 weeks after booster
injections in the present study, and the similar de-
crease reported in rhesus macaques (Chappel et
al, 1980) and bulls (Robertson et al, 1981) following
booster injections, suggests that repeated expo-
sure to immunogen will be required.
Results of this study indicate 1) that normal tes-
ticular function in sexually mature mongrel dogs
requires a continuous supply of the neurohor-
mone, LHRH (Jones et al, 1976), and 2) that neu-
tralization of endogenous LHRFI by active immu-
nization may provide a suitable alternative to sur-
gical castration in the dog.
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